In vitro assessment of hepatotoxicity by metabolomics: a review

被引:49
作者
Cuykx, Matthias [1 ,2 ]
Rodrigues, Robim M. [2 ]
Laukens, Kris [3 ,4 ]
Vanhaecke, Tamara [2 ]
Covaci, Adrian [1 ]
机构
[1] Univ Antwerp, Toxicol Ctr, Univ Pl 1, B-2610 Antwerp, Belgium
[2] Vrije Univ Brussel, Dept Vitro Toxicol & Dermato Cosmetol, Laarbeeklaan 103, B-1090 Brussels, Belgium
[3] Univ Antwerp, Dept Math & Comp Sci, Middelheimlaan 1, B-2020 Antwerp, Belgium
[4] Univ Antwerp, Biomed Informat Network Antwerpen Biomina, Middelheimlaan 1, B-2020 Antwerp, Belgium
关键词
Metabolomics; In vitro; Liver; Hepatotoxicity; Drug-induced liver injury (DILI); LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; EXPERIMENTAL-DESIGN; LARGE-SCALE; METABOLITE IDENTIFICATION; REPORTING STANDARDS; PRIMARY HEPATOCYTES; SAMPLE PREPARATION; LIPID EXTRACTION; DRUG-METABOLISM;
D O I
10.1007/s00204-018-2286-9
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Omics technologies, and in particular metabolomics, have received an increasing attention during the assessment of hepatotoxicity in vitro. However, at present, a consensus on good metabolomics practices has yet to be reached. Therefore, in this review, a range of experimental approaches, applied methodologies, and data processing workflows are compared and critically evaluated. Experimental designs among the studies are similar, reporting the use of primary hepatocytes or hepatic cell lines as the most frequently used cell sources. Experiments are usually conducted in short time-frames (< 48 h) at sub-toxic dosages. Applied sample preparations are protein precipitation or Bligh-and-Dyer extraction. Most analytical platforms rely on chromatographic separations with mass spectrometric detection using high-resolution instruments. Untargeted metabolomics was typically used to allow the simultaneous detection of several classes of the metabolome, including endogenous metabolites that are not initially linked to toxicity. This non-biased detection platform is a valuable tool for generating hypothesis-based mechanistic research. The most frequently reported metabolites that are altered under toxicological impulses are alanine, lactate, and proline, which are often correlated. Other unspecific biomarkers of hepatotoxicity in vitro are the down-regulation of choline, glutathione, and 3-phospho-glycerate. Disruptions on the Krebs cycle are associated with increased glutamate, tryptophan, and valine. Phospholipid alterations are described in steatosis, lipo-apoptosis, and oxidative stress. Although there is a growing trend towards quality control, data analysis procedures do often not follow good contemporary metabolomics practices, which include feature filtering, false-discovery rate correction, and reporting the confidence of metabolite annotation. The currently annotated biomarkers can be used to identify hepatotoxicity in general and provide, to a certain extent, a tool for mechanistic distinction.
引用
收藏
页码:3007 / 3029
页数:23
相关论文
共 120 条
[1]   Anionic metabolite profiling by capillary electrophoresis-mass spectrometry using a noncovalent polymeric coating. Orange juice and wine as case studies [J].
Acunha, Tanize ;
Simo, Carolina ;
Ibanez, Clara ;
Gallardo, Alberto ;
Cifuentes, Alejandro .
JOURNAL OF CHROMATOGRAPHY A, 2016, 1428 :326-335
[2]   CFM-ID: a web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra [J].
Allen, Felicity ;
Pon, Allison ;
Wilson, Michael ;
Greiner, Russ ;
Wishart, David .
NUCLEIC ACIDS RESEARCH, 2014, 42 (W1) :W94-W99
[3]   Analytical methods in untargeted metabolomics: state of the art in 2015 [J].
Alonso, Arnald ;
Marsal, Sara ;
Julia, Antonio .
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2015, 3
[4]   Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis [J].
Alonso, Cristina ;
Fernandez-Ramos, David ;
Varela-Rey, Marta ;
Martinez-Arranz, Ibon ;
Navasa, Nicolas ;
Van Liempd, Sebastiaan M. ;
Lavin Trueba, Jose L. ;
Mayo, Rebeca ;
Ilisso, Concetta P. ;
de Juan, Virginia G. ;
Iruarrizaga-Lejarreta, Marta ;
delaCruz-Villar, Laura ;
Minchole, Itziar ;
Robinson, Aaron ;
Crespo, Javier ;
Martin-Duce, Antonio ;
Romero-Gomez, Manuel ;
Sann, Holger ;
Platon, Julian ;
Van Eyk, Jennifer ;
Aspichueta, Patricia ;
Noureddin, Mazen ;
Falcon-Perez, Juan M. ;
Anguita, Juan ;
Aransay, Ana M. ;
Luz Martinez-Chantar, Maria ;
Lu, Shelly C. ;
Mato, Jose M. .
GASTROENTEROLOGY, 2017, 152 (06) :1449-+
[5]   Strategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studies [J].
Amacher, David E. .
TOXICOLOGY, 2011, 279 (1-3) :10-18
[6]   Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications [J].
Amathieu, Roland ;
Triba, Mohamed Nawfal ;
Goossens, Corentine ;
Bouchemal, Nadia ;
Nahon, Pierre ;
Savarin, Philippe ;
Le Moyec, Laurence .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (01) :417-426
[7]   Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells [J].
Aninat, C ;
Piton, A ;
Glaise, D ;
Le Charpentier, T ;
Langouët, S ;
Morel, F ;
Guguen-Guillouzo, C ;
Guillouzo, A .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (01) :75-83
[8]   Optimization of the HepaRG cell model for drug metabolism and toxicity studies [J].
Antherieu, Sebastien ;
Chesne, Christophe ;
Li, Ruoya ;
Guguen-Guillouzo, Christiane ;
Guillouzo, Andre .
TOXICOLOGY IN VITRO, 2012, 26 (08) :1278-1285
[9]   Linking energy metabolism to dysfunctions in mitochondrial respiration - A metabolomics in vitro approach [J].
Balcke, G. U. ;
Kolle, S. N. ;
Kamp, H. ;
Bethan, B. ;
Looser, R. ;
Wagner, S. ;
Landsiedel, Robert ;
van Ravenzwaay, B. .
TOXICOLOGY LETTERS, 2011, 203 (03) :200-209
[10]   Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells [J].
Bi, Huichang ;
Krausz, Kristopher W. ;
Manna, Soumen K. ;
Li, Fei ;
Johnson, Caroline H. ;
Gonzalez, Frank J. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2013, 405 (15) :5279-5289